Ingenious Medtech Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
- Paid Up Capital ₹ 9.39 M
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.08%
- Profit Growth -216.72%
- Ebitda -315.14%
- Net Worth -24.67%
- Total Assets 8.39%
About Ingenious Medtech
Ingenious Medtech Private Limited (IMPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 December 2016 (Eight years and two months 7 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 9.39 M, as per Ministry of Corporate Affairs (MCA) records.
Shantanu Mayekar, Sneha Mayekar, and Pavel Bohdal serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC288080
-
Company No.
288080
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Ingenious Medtech Private Limited offer?
Ingenious Medtech Private Limited offers a wide range of products and services, including Endoscopy & Laparoscopy instruments, Surgical Equipments.
Who are the key members and board of directors at Ingenious Medtech?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sneha Mayekar
|
Director | 01-Dec-2016 | Current |
|
Shantanu Mayekar
|
Director | 01-Dec-2016 | Current |
Pavel Bohdal
|
Director | 27-Jan-2017 | Current |
Financial Performance of Ingenious Medtech.
Ingenious Medtech Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.08% decrease. The company also saw a substantial fall in profitability, with a 216.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ingenious Medtech?
In 2023, Ingenious Medtech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ingenious Medtech?
Unlock and access historical data on people associated with Ingenious Medtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ingenious Medtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ingenious Medtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.